The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sherwood Charles H since 2007.
The trader's CIK number is 1244298.
At the time of the last reporting, Sherwood Charles H was the President & CEO of Anika Therapeutics, Inc.. (stock ticker symbol ANIK).
Also see all insider trading activities at Anika Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ANIK | 0 | $0 | 119,914 | $6,468,142 | 0 | $0 |
| 2014 | ANIK | 0 | $0 | 283,780 | $12,053,129 | 337,530 | $2,920,984 |
| 2013 | ANIK | 0 | $0 | 160,694 | $3,054,377 | 100,000 | $921,998 |
| 2012 | ANIK | 0 | $0 | 0 | $0 | 90,000 | $97,250 |
| 2011 | ANIK | 0 | $0 | 0 | $0 | 102,500 | $119,924 |
| 2010 | ANIK | 0 | $0 | 0 | $0 | 25,000 | $173,450 |
| 2008 | ANIK | 0 | $0 | 60,000 | $554,782 | 75,000 | $393,750 |
| 2007 | ANIK | 0 | $0 | 10,000 | $200,299 | 265,000 | $293,984 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-10-24 | ANIK | Sale | 3,278 | 60.04 | 196,811 |
| 2017-10-23 | ANIK | Sale | 22,228 | 60.06 | 1,335,013 |
| 2017-10-20 | ANIK | Sale | 5,991 | 60.04 | 359,699 |
| 2017-10-16 | ANIK | Sale | 3,293 | 60.04 | 197,711 |
| 2017-10-13 | ANIK | Sale | 5,216 | 60.11 | 313,533 |
| 2017-10-12 | ANIK | Sale | 1,908 | 60.00 | 114,480 |
| 2017-07-27 | ANIK | Sale | 63,799 | 50.79 | 3,240,351 |
| 2017-07-05 | ANIK | Sale | 8,236 | 50.06 | 412,294 |
| 2017-07-03 | ANIK | Sale | 5,965 | 50.00 | 298,250 |
| 2014-05-05 | ANIK | Option Ex | 337,530 | 8.65 | 2,920,984 |
| 2014-05-01 | ANIK | Sale | 83,780 | 44.32 | 3,713,129 |
| 2014-02-28 | ANIK | Sale | 150,000 | 41.09 | 6,163,500 |
| 2014-02-27 | ANIK | Sale | 50,000 | 43.53 | 2,176,500 |
| 2013-07-11 | ANIK | Option Ex | 14,306 | 9.22 | 131,901 |
| 2013-07-12 | ANIK | Sale | 64,544 | 20.03 | 1,292,816 |
| 2013-07-15 | ANIK | Sale | 10,456 | 20.63 | 215,707 |
| 2013-07-09 | ANIK | Sale | 1,321 | 18.11 | 23,923 |
| 2013-07-08 | ANIK | Sale | 47,864 | 18.06 | 864,423 |
| 2013-07-09 | ANIK | Option Ex | 1,321 | 9.22 | 12,179 |
| 2013-07-08 | ANIK | Option Ex | 47,864 | 9.22 | 441,306 |
| 2013-07-05 | ANIK | Sale | 21,157 | 18.01 | 381,037 |
| 2013-07-03 | ANIK | Option Ex | 13,505 | 9.22 | 124,516 |
| 2013-07-03 | ANIK | Sale | 13,505 | 18.01 | 243,225 |
| 2013-07-05 | ANIK | Option Ex | 21,157 | 9.22 | 195,067 |
| 2013-06-19 | ANIK | Option Ex | 1,847 | 9.22 | 17,029 |
| 2013-06-19 | ANIK | Sale | 1,847 | 18.00 | 33,246 |
| 2012-12-07 | ANIK | Option Ex | 40,000 | 1.05 | 42,000 |
| 2012-03-14 | ANIK | Option Ex | 50,000 | 1.10 | 55,250 |
| 2011-06-09 | ANIK | Option Ex | 102,500 | 1.17 | 119,924 |
| 2010-01-04 | ANIK | Option Ex | 25,000 | 6.94 | 173,450 |
| 2008-03-14 | ANIK | Sale | 2,914 | 8.43 | 24,576 |
| 2008-03-13 | ANIK | Sale | 15,000 | 9.23 | 138,450 |
| 2008-03-14 | ANIK | Option Ex | 30,000 | 5.25 | 157,500 |
| 2008-03-13 | ANIK | Option Ex | 15,000 | 5.25 | 78,750 |
| 2008-03-14 | ANIK | Sale | 3,100 | 9.04 | 28,039 |
| 2008-03-14 | ANIK | Sale | 8,986 | 8.71 | 78,223 |
| 2008-03-12 | ANIK | Sale | 6,300 | 9.41 | 59,283 |
| 2008-03-12 | ANIK | Sale | 8,700 | 9.21 | 80,170 |
| 2008-03-11 | ANIK | Sale | 4,909 | 9.90 | 48,613 |
| 2008-03-12 | ANIK | Option Ex | 15,000 | 5.25 | 78,750 |
| 2008-03-11 | ANIK | Option Ex | 15,000 | 5.25 | 78,750 |
| 2008-03-11 | ANIK | Sale | 10,091 | 9.65 | 97,428 |
| 2007-07-30 | ANIK | Sale | 5,000 | 20.02 | 100,109 |
| 2007-07-31 | ANIK | Sale | 5,000 | 20.04 | 100,190 |
| 2007-07-30 | ANIK | Option Ex | 10,000 | 1.17 | 11,700 |
| 2007-01-29 | ANIK | Option Ex | 127,500 | 1.11 | 141,142 |
| 2007-01-29 | ANIK | Option Ex | 127,500 | 1.11 | 141,142 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sherwood Charles H (President & CEO of Anika Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.